Genetic determinants of multi-drug resistance in Acinetobacter baumannii at an academic hospital in Pretoria, South Africa
Preprint
Abstract
Antimicrobial resistance is now globally recognised as the greatest threat to human health. Acinetobacter baumanniis’ ( A. baumannii ) clinical significance has been driven by its ability to obtain and transmit antimicrobial resistance factors. In South Africa, A. baumannii is a leading cause of healthcare associated infections (HAI). In this study, we investigated the genetic determinants of multi-drug resistant A. baumannii (MDRAB) at a teaching hospital in Pretoria, South Africa. One hundred non repetitive isolates of A. baumannii were collected for the study at Dr George Mukhari Tertiary Laboratory (DGMTL). Antimicrobial susceptibility testing was performed using the VITEK2 system (bioMerieux, France). The prevalence of common resistance associated genes and AdeABC efflux pump system associated genes were investigated using conventional PCR. Genetic relatedness of isolates was then determined using rep-PCR. Seventy (70) of 100 isolates collected were confirmed to be multi-drug resistant and were bla OXA51 positive. Phenotypically, the isolates where resistant to almost all tested antibiotics. However, one isolate showed intermediate susceptibility to tigecycline while all were susceptible to colistin. Oxacillinase encoding gene bla OXA-23 was the most detected at 99% and only 1% was positive for bla OXA-40 . The PCR results for metallo-betalactamase (MBL) encoding genes showed that MBL bla VIM was the most frequently detected at 86% and bla SIM-1 at 3% was the least detected. Out of 70 isolates, 56 isolates had the required gene combination for an active efflux pump. The most prevalent clone was clone A at 69% of the isolates. Regarding treatment; colistin and tigecycline are the most effective against strains encountered at DGMTL as all tested carbapenems seem to have lost their effectiveness. The major genotypic determinants for drug resistances are oxacillinases: bla OXA-51 (100%) and bla OXA-23 (99%). The study reports for the first time, bla OXA-40 and bla SIM-1 detection in A. baumannii in South Africa.Keywords
All Related Versions
- Published version: International Journal of Infectious Diseases, 101, 35.
This publication has 43 references indexed in Scilit:
- High prevalence of oxacillinases in clinical multidrug-resistant Acinetobacter baumannii isolates from the Tshwane region, South Africa – an updateBMC Infectious Diseases, 2015
- Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant acinetobacter baumanniiInternational Journal of Infectious Diseases, 2015
- Update on the antibiotic resistance crisisCurrent Opinion in Pharmacology, 2014
- Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2013
- Prevalence of carbapenem resistance genes inAcinetobacter baumanniiisolated from clinical specimens obtained from an academic hospital in South AfricaSouthern African Journal of Epidemiology and Infection, 2013
- In vitro activity of tigecycline against clinical isolates of carbapenem resistant Acinetobacter baumannii complex in Pretoria, South AfricaBMC Research Notes, 2012
- Multidrug resistant AcinetobacterJournal of Global Infectious Diseases, 2010
- Safety and effectiveness of colistin compared with tobramycin for multi-drug resistant Acinetobacter baumannii infectionsBMC Infectious Diseases, 2009
- Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumanniiClinical Microbiology and Infection, 2006
- Emergence of multi-drug-resistantAcinetobacter anitratusspecies in neonatal and paediatric intensive care units in a developing country: concern about antimicrobial policiesPaediatrics and International Child Health, 2001